Evidence map›Paper›PMID 42340065›Full record

ArticleCancer science2026

RETRACTION: Reactivation of p53 in cells expressing hepatitis B virus X-protein involves p53 phosphorylation and a reduction of Hdm2.

Abstract readRetraction Notice
In one paragraph

Article in Cancer science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

0 authors.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

retractionJ.-H. Wang, C. Yun, S. Kim, S. Chae, Y. I. Lee, W.-H. Kim, J.-H. Lee, W. Kim and H. Cho, "Reactivation of p53 in cells expressing hepatitis B virus X-protein involves p53 phosphorylation and a reduction of Hdm2," Cancer Science 99, no. 5 (2008): 888-893, https://doi.org/10.1111/j.1349-7006.2008.00754.x. The above article, published online on 24 February 2008 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Masanori Hatakeyama; the Japanese Cancer Association; and John Wiley & Sons Australia Ltd. The retraction has been agreed following concerns raised by a third party. An investigation identified multiple instances of image duplication between the Chang and ChangX-34 α-tubulin bands shown in Figure 1a. Further duplications were identified between the HeLa α-tubulin bands in Figure 1a and the Dox α-tubulin bands in Figure 3a. In addition, the cytosol phospho-p53 (Ser 15), Lamin B, and nuclear α-tubulin panels in Figure 4a were found to have identical backgrounds. The authors were contacted for their comments and supporting data. Due to the time that has elapsed since publication, the data are no longer available. The authors do not agree that the western blot bands or panels were duplicated. The editors consider the results and conclusions to be unreliable. The authors H. Cho and J.-H. Wang disagree with the retraction. The remaining authors did not respond to our notice of retraction.

Identifiers

PMID42340065
PMCPMC13394791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.